New pill provides a meaningful step forward for those fighting a rare and debilitating disease
The FDA approved a first-of-its-kind oral drug for dermatomyositis, a rare autoimmune disease. Trials showed the drug improved muscle and skin outcomes — but not without risk.
Original Source
Read the full article at Al →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.